Goodyear Tire & Rubber Co vs Illumina, Inc. — how do they compare? Goodyear Tire & Rubber Co trades at $4.68 (market cap $1.37B), while Illumina, Inc. trades at $278.17 (market cap $39.95B). The key difference: Illumina, Inc. is far larger — about 29.2× Goodyear Tire & Rubber Co's market cap, and Illumina, Inc. is trading nearer its 52-week high, Goodyear Tire & Rubber Co nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Goodyear Tire & Rubber Co for 57 Days and Illumina, Inc. for 83 Days on average.
| GT | ILMN | |
|---|---|---|
Market Cap | $1.37B | $39.95B |
Volume | 9,470,773 | 3,169,503 |
Sector | Consumer Cyclical | Health |
52-Week High | $10.54 | $293.69 |
52-Week Low | $4.66 | $91.00 |
Typical Hold Time | 57 Days | 83 Days |
Enterprise Value | $8.72B | $41.31B |
Signals from Pluang's Aura AI — not financial advice
The Goodyear Tire & Rubber Company (GT) trades at $4.75, down 1.28% with a bearish technical outlook. The stock shows attractive valuation metrics with P/E of 4.69 and P/B of 0.48, but faces fundamental challenges including negative net income margin of -14.37% and ROE of -63.93%. Recent earnings showed mixed results with Q2 2026 beating expectations despite a loss, while the company executes a restructuring strategy focusing on premium EV tires.
GT presents a high-risk opportunity with significant upside potential given the $8.00 consensus price target, but investors face substantial execution risks amid ongoing restructuring, declining revenues, and persistent losses. The bearish technicals and mixed analyst sentiment (34.62% buy rating) suggest cautious optimism dependent on successful turnaround execution and margin improvement.
ILMN trades at $264.40, down 1.25% on the day, but remains near its recent 52-week high of $278.99 (Defense World, 2026-10-01). The stock has surged 94.9% year-to-date (Zacks Investment Research, 2026-09-24), supported by strong earnings beats in recent quarters and a bullish technical trend. Fundamentals show a significant turnaround, with 2025 net income reaching $850 million after prior losses, though valuation ratios like a P/E of 49.36 are elevated. The pending inclusion in the S&P 500 (PRNewsWire, 2026-09-04) adds a positive catalyst.
The outlook is positive, driven by sequencing growth, AI integration in genomics, and improved profitability. However, risks include high valuation sensitivity, cost volatility, and competitive pressures in the life sciences sector. Analyst consensus is bullish with a 54% buy rating, but the average price target of $241 suggests limited near-term upside from current levels.
Trailing returns across standard periods
Latest headlines on both assets
Goodyear Tire & Rubber Co manufactures and sells a variety of rubber tires under the Goodyear brand name. The firm's tires are used for automobiles, trucks, buses, aircraft, motorcycles, mining equipment, farm equipment, and industrial equipment.
Read more on GT →Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput technology enables whole genome sequencing in humans and other large organisms. Its lower throughput tools enable applications that require smaller data outputs, such as viral and cancer tumor screening. Illumina also sells microarrays (less than 10% of sales) that enable lower-cost, focused genetic screening with primarily consumer and agricultural applications.
Read more on ILMN →